Mastery EAQ Ch. 30

A  Corticotropin

B  Desmopressin

C  Somatropin

D  Octreotide

A  Desmopressin

B  Octreotide

C  Somatropin

D  Vasopressin

A  “Skip the missed dose and resume your usual dosage schedule.”

B  “You can take the dose immediately when you remember it.”

C  “You should consult your primary health care provider immediately.”

D  “If it is almost time for your next dose, take a double dose of the drug at that time.”

A  Somatropin

B  Vasopressin

C  Cosyntropin

D  Desmopressin

A  Abdominal stress

B  Drowsiness

C  Vertigo

D  Bleeding gums

A  “Shake the medication before administration.”

B  “Keep the bottle in warm water before administration.”

C  “Heat the medicine before administration.”

D  “Do not administer the drug to the patient.”

A  Evaluate the patient for limping.

B  Monitor fluid status.

C  Encourage vigorous exercise.

D  Monitor blood glucose levels closely.

A  Obtaining liver and renal function tests

B  Co-administering carbamazepine

C  Administering the vasopressin intravenously

D  Monitoring the patient in an intensive care unit

A  Abdominal cramps

B  Excessive thirst

C  Bleeding gums

D  Limping

A  Low blood pressure, Blood glucose elevation, Headache, Low urine output

B  Headache, Low urine output, Low blood pressure, Nausea

C  Nausea, Blood glucose elevation, Headache, Low urine output

D  Nausea, Blood glucose elevation, Headache, Low blood pressure

A  Octreotide subcutaneous

B  Somatropin intramuscular

C  Desmopressin intravenously

D  Vasopressin nasal spray

A  Liver enzymes

B  Blood glucose

C  Electrocardiogram (ECG)

D  Renal panel

A  Radiology report identifies no fracture with closed growth plates.

B  Previous somatropin injection site tender to touch.

C  Reports episodic muscle pain during the past year.

D  Growth percentile has increased from the previous annual physical.

A  Review the frequency with the health care provider

B  Obtain baseline weight and height measurements

C  Calculate the dosage with the pharmacist or another nurse

D  Review current laboratory values for blood glucose

A  Notice increase in body temperature

B  Assess the patient for headaches

C  Inquire about abdominal discomfort

D  Monitor for signs of infiltration

A  Edema of the extremities, Elevated blood pressure

B  Elevated blood pressure, Weight gain

C  Weight gain, Edema of the extremities

D  Increased urination, Thirst

A  Watch the IV site closely for infiltration.

B  Assess for signs of dehydration.

C  Measure the patient’s urine output regularly.

D  Make a note of the fluid intake.

A  Acromegaly and a serum creatinine level of 5.0 mg/dL

B  Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

C  Small-bowel fistula and having an acute asthma attack

D  Esophageal varices and a history of type 2 diabetes

A  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

B  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Replace the cap on the bottle.
5. Give half a spray in each nostril.
6. Monitor the level of drug left in the pump.

C  1. Clear the nasal passages.
2. Prime the pump by pressing down four times.
3. Place the spray nozzle in the nostril.
4. Give half a spray in each nostril.
5. Monitor the level of drug left in the pump.
6. Replace the cap on the bottle.

D  1. Clear the nasal passages.
2. Give half a spray in each nostril.
3. Place the spray nozzle in the nostril.
4. Prime the pump by pressing down four times.
5. Replace the cap on the bottle.
6. Monitor the level of drug left in the pump.

A  Patient C: VIP; life-threatening hypotension; diarrhea and flushing

B  Patient A: esophageal varices; type 1 diabetes

C  Patient B: carcinoid tumor; taking ciprofloxacin

D  Patient D: VIP; severe diarrhea and flushing; renal impairment

A  Headache, Joint pain

B  Diarrhea, Flushing

C  Joint pain, Fatigue

D  Fatigue, Headache

A  The patient is stable and needs reassurance.

B  A higher dose of medication is required for treatment.

C  The medication is not effective for this condition.

D  The patient needs to adjust fluid intake.

A  Storing the pump at room temperature

B  Administering half the dose in each nostril

C  Inhaling the medication into the airway

D  Priming the pump each week

A  “Is there any change in the color of your sputum?”
“Do you have excessive bleeding due to minor injuries?”

B  “Do you feel very thirsty lately?”
“How many times do you urinate in a day?”

C  “Do you have excessive bleeding due to minor injuries?”
“Is there any change in the color of your urine?”

D  “Is there any change in the color of your urine?”
“Is there any change in the color of your sputum?”

A  Height, Weight, Motor skills

B  Skin turgor, Height, Visual acuity

C  Weight, Skin turgor, Visual acuity

D  Motor skills, Visual acuity, Skin turgor

A  Pressing the pump once to spray a 10-mcg dose

B  Replacing the cap on the pump after the procedure

C  Pressing down on the pump two times to prime it

D  Priming the nasal pump once a week

A  Hypercalciuria

B  Hypothyroidism

C  Hyperglycemia

D  Hypertension

A  “Dilute the drug preparation before administration.”

B  “Inhale the drug preparation by spraying into the nostrils.”

C  “Shake the drug preparation thoroughly before use.”

D  “Apply the drug preparation topically to the nasal membranes.”

A  Watery diarrhea

B  Loss of consciousness

C  Abundant, diluted urine

D  Oozing blood

A  Human immunodeficiency virus (HIV) infection

B  Acute bronchitis with laryngitis

C  Bilateral metastatic breast cancer

D  Cachexia and closed growth plates

A  A 7-year-old diagnosed with growth hormone deficiency

B  An 8-year-old with a pituitary tumor

C  A 10-year-old of short stature who has severe asthma

D  A 17-year-old who is 5 feet tall

A  Vasopressin and demeclocycline

B  Desmopressin and carbamazepine

C  Somatropin and glucocorticoids

D  Vasopressin and carbamazepine

A  Heartburn

B  Seizures

C  Hypoglycemia

D  Edema

A  Hyponatremia

B  Hyperglycemia

C  Hypokalemia

D  Orthostatic hypotension

A  Cyclosporine

B  Fludrocortisone

C  Ciprofloxacin

D  Glucocorticoids

A  Diabetes insipidus, Seizure, Type I von Willebrand

B  Asthma, Diabetes insipidus, Type I von Willebrand

C  Seizure, Asthma, Cardiovascular disease

D  Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

A  Decreases growth

B  Decreases fluid retention

C  Reduces fat levels

D  Reduces weight loss

A  Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

B  Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

C  Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

D  Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

A  Acetaminophen

B  Thioridazine

C  Carbamazepine

D  Norepinephrine

A  Liver enzyme levels, Blood glucose levels, Renal function studies

B  Weight, Blood pressure, Blood glucose levels

C  Renal function studies, Liver enzyme levels, Blood pressure

D  Liver enzyme levels, Renal function studies, Weight

A  Dyspnea, Constipation, Hypercalciuria

B  Malaise, Dyspnea,

C  Constipation, Malaise, Hypercalciuria

D  Arthralgia, Hypercalciuria, Constipation

A  Inflammation

B  Scar formation

C  Hypotension

D  Edema

A  Reduces the effects of desmopressin

B  Causes prolongation of QT interval

C  Enhances the effects of desmopressin

D  Produces an additive effect

A  Somatropin

B  Octreotide

C  Vasopressin

D  Desmopressin

A  Somatropin

B  Cosyntropin

C  Desmopressin

D  Octreotide

A  Polydipsia

B  Dehydration

C  Headache

D  Polyuria

A  Cosyntropin

B  Octreotide

C  Thyroid hormone

D  Oxytocin

A  Ciprofloxacin

B  Demeclocycline

C  Cyclosporine

D  Carbamazepine

A  Creatinine clearance test

B  Blood glucose level

C  Complete blood count result

D  Uric acid level

A  Desmopressin

B  Somatropin

C  Luteinizing hormone

D  Vasopressin

A  Acromegaly

B  Hypopituitary dwarfism

C  Polyuria

D  Polydipsia

A  Octreotide

B  Cosyntropin

C  Oxytocin

D  Vasopressin

A  Somatropin

B  Choriomammotropin

C  Somatostatin

D  Somatolactin

A  Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

B  Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

C  Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

D  Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

A  Increased urine specific gravity

B  Relief of pain

C  Increased serum albumin levels

D  Decreased adrenocorticotropic hormone levels